Mexico Health Summit 2021 Merged

Page 1

IMPACT REPORT


As the country fights its way through the COVID-19 pandemic, the Mexican health sector strives to consolidate a fragmented service network while overcoming the challenges of both medicine and care shortages. At the same time, Mexico keeps growing its manufacturing muscle in both pharmaceutical and medical devices segments, creating new investment opportunities. The success of the Mexican health industry will be defined by the business and political leaders shaping its future today. We bring these leaders together at Mexico Health Summit to exchange essential industry information, expertise and opportunities, to find solutions to overcome industry challenges, to connect financing and opportunities, to match supply and demand and to accelerate innovation. In 2021, the two editions of Mexico Health Summit brought together 630 industry leaders representing 295 companies, welcomed 124 speakers, generated 2,586 matchmaking interactions that resulted in 306 high-level 1:1 meetings, and generated 975 pre-qualified leads for 20 sponsors. In 2022, we will continue maximizing the impact of our conferences for participants, speakers and sponsors. Our conference programs will offer inside perspectives on the topics that matter most, and are designed to help industry leaders make better decisions and drive results. By leveraging leading-edge technology and artificial intelligence, we will deliver unprecedented matchmaking and lead-generation results at a time when connecting supply and demand remains challenging. We look forward to helping you achieve your marketing, commercial and strategic objectives!


J a n u ar y 2 7 - 2 9 , 2 0 2 1

Gold Sponsors

Registration Sponsor

Silver Sponsors


S e pt e mb e r 0 8 - 1 0 , 2 0 2 1

Platinum Sponsor

Networking Sponsor

Gold Sponsors

Silver Sponsors


5

C o n f e r e n c e I mpact

295

companies

630

conference participants

How would you rate the quality of the conference program and speakers?

47% Meets expectation 33% Exceeds expectations 11% Greatly exceeds expectations 9% Below expectations

124

Breakdown by job title

29.7% Director 24.5% Manager 18.5% CEO/Director General 10.2% Associate / Executive 6.7% President / Board Member / Partner 4% Doctor 3.7% VP / CFO / COO 2.7% Researcher / Analyst

speakers

20

sponsors

Conference social media impact 22,150 direct impressions during MHS

4,003

visitors to the conference website

Pre-conference social media impact 86,334 direct pre-conference LinkedIn impressions

11% click through rate during MHS

9.98% pre-conference click through rate

10.28% conference engagement rate

5.14% pre-conference engagement rate

Mexico’s leading B2B conference organizer introduces the world’s leading event networking platform. Delivering intent-based matchmaking powered by Artificial Intelligence that connects the right people. Network, no matter where you are.

477

participants

How would you rate the quality of the matchmaking on Brella?

Matchmaking intentions

2,586

matchmaking communications

306

1:1 meetings conducted

46.7% 26.7% 15.6% 11%

Meets expectation Exceeds expectations Below expectations Greatly expectations

2,057 Trading Total

4,597

242 Recruitment 617 Investment 1,681 Networking


6

C ompa n y Att e n da n c e •

Abbott Laboratories, Inc.

Brightsea

Everis

AbbVie

Bristol Myers Squibb

FANASA

Accord Farma

British Embassy in Mexico

Aes

Bupa

Farmacéuticos Maypo, S.A. de C.V.

Aesculapius Baer

Cal y Mayor

AIDICARE

Canifarma

Farmacia Guadalajara, SA de CV

Akza

Cardinal Health

Farmacias ISSEG

Alivia Clinica de Alta Especialidad

Carestream

Central Media

Farmacos Continentales S. A de C.V

Allen Laboratorios

Centro de Investigación Sophia

Farmalisto

Allergan

Centro Médico ABC

FARMAPIEL

Alvarez & Marsal

CHG Meridian Mexico

Farmcias Yza

Amazon

Chiesi Mexico

Ferring

Ambar Capital

Fronier View

AMELAF

CHRISTUS Center of Excellence and Innovation

FrontierView

AMID Asociacion Mexicana de Industrias Innovadoras de Dispositivos Médicos AC

Christus Muguerza

Circutor

Fundación Mexicana para la Salud.A.C.

CISNE México (Centro de Investigación en Sistema Nervioso)

Generac México

General Consulate of Canada

Genetics and Health SA de CV

AMIIF

Anadim

Analitek- Bio satefy

Citieffe

Gilead

ANICANN

City Cancer Challenge

Gobierno de Ontario en Mexico

Apolo Health

City Council

Google

Apotex

Cluster Medico Jalisco

Google Cloud

ARROBA INGENIERIA, SA DE CV

Cold Chain Technologies

GRE Relaciones Estratégicas

COLORCON

Ascendis Capital

Asociación mexicana de diabetes en la Ciudad de México AC

Consejo Coordinador Empresarial

Grupo Angeles Serivicios de Salud

Grupo Bruluart

Consejo de Salubridad General

GRUPO DALINDE SAN ANGEL INN

Asociación Mexicana de Laboratorios Farmacéuticos, A.C.

Consejo Mexicano de Nuerología

Grupo GS México

Consejo Mexicano de Ortopedia y Traumatología

Grupo Médico Rossano

Asociación Mexicana de Laboratorios Farmacéuticos

Consorcio Mexicano de Hospitales

Grupo Promotor de la Industria de Cannabis

Grupo Sanfer

ASPEN LABS

ConvaTec Mexico

Grupo Torre Médica

Astellas

Croda

Grupo Viso

Atramat

DEG

GSK

AVA Salud

DELL Technologies

HL7 México

Avalon Pharmaceutical

DocPlanner

Hospital Ginequito

AXA Seguros México

Dräger

Hospital Moscati

Axios International

Ecaresoft Inc.

Baker Mackenzie

Becerril, Coca & Becerril

Edwards Lifesciences Mexico SA de CV

Hospital San Angel Inn Chapultepec

Hospitales San Angel Inn

Beckman Coulter

Ekomite

Hospitales Star Medica

Biocodex de Mexico

Eli Lilly & Company

Hospitaria

BioMérieux

Embassy of Canada in Mexico

ICAN

BIOSKINCO

Icon Group

Boehringer Ingelheim

Embassy of the Netherlands in Mexico

IMSS

Boston Scientific

Energy to Market

IMSS ABC

BPF part of WbD Group

Eolis

Indra

Brella Ltd

Ergotron

Inosan Biopharma


7

C ompa n y Att e n da n c e •

Instituto de Salud Pública de Chile

MexicoView

Social Diabetes

Microport

Instituto Mexicano del Seguro Social

Minsait Indra

Sociedad Mexicana de Oncología

Moksha8

SOHIN

Insumos para la Salud

MSD

Somar

INTERACIONAL FARMACEUTICA

Multiplica

Stripe

Multivac

Synthon Mexco

Internacional Farmaceutica

Mural Med

T5DC

Investigacion Farmaceutica

Nadro

Takeda

IQVIA

Newlink

Tec Salud

Janssen

Novartis

Teconológico de Monterrey

Johnson & Johnson

Olivares

Teva Pharmaceuticals

Jones Day

Olympus

TIS

Kaspersky

Omron

Tokio Marine Mexico

Kimberley Clark

Pantaleon

Total Integridad & Certeza

Klockner Pentaplast

Pascual Asesoria

Trifermed

Kuehne Nagel

perrigo mexico

Trilations

Laboratorio Médico Polanco

Pharma Advice

Trout & Partners

Laboratorios Alfasigma

Pierre Fabr

UANL

Laboratorios de Especialidades Inmnuológicas

PLM

UCIN MEDICA

Prevem Seguros

UDIMEB

Laboratorios Liomont

QbD México

ULTRA LABORATORIOS

Laboratorios Sanfer

Reinsurance Company

Ultragenyx Pharmaceuticals

Laboratorios Sophia

RGA

LAVARTEX

RM Pharma Specialist

UNIVERSIDAD DE GUADALAJARA

Life Sciences Consultants

Roche

Universidad de Monterrey

LMP

San Luis Potosi City Council

Universidad Iberoamericana

MAG Medical Group

Sanchez Devanny

Veeam

Mayo Clinic

Sandoz Mexico

Vitamedica

Medartis

Sanofi

Viveo Health

Medica Sur

SARSTEDT MEXICO

Von Wobeser y Sierra

MediHC

Sartorius

Willscot

Medisi America

SBL Pharmaceutical

Within3

Medistik

Seca

Wood

Medix

Zacsoft

Medtronic

Sericio de Logística Empresarial y Comercial

Zydus Pharmaceuticals Mexico

Merck

Siemens Healthineers

Mexico Salud

Silanes


8

J a n u ar y 2 7 T H , 2 0 2 1

09:00 STATE OF THE SECTOR: FROM STRUCTURAL REFORMS TO COVID-19 Speaker: Patrick Devlyn, President of the Health Commission at CCE 09:45

THE HEALTHCARE SECTOR IN THE NATIONAL ECONOMY

Moderator: Juan de Villafranca, Executive Director of the Mexican Association of Pharmaceutical Laboratories (AMELAF) Panelists: Arturo Morales, Corporate Affairs Director at Landsteiner Scientific and President of AMELAF Deyanira Chiñas, Commercial Director of T5DC and President of the National College of Pharmaceutical Biologists of Mexico Carlos López Patán, Director General of Medix Luis Verduzco, Director General of Gelpharma Fernando Riedel, CEO of SBL Pharmaceuticals 10:30

PHARMACEUTICAL INDUSTRY GOING THROUGH INTENSE THERAPY

Moderator: Rafael Gual, Director General of the National Chamber of the Pharmaceutical Industry (CANIFARMA) Panelists: Arturo de la Rosa, General Manager of AbbVie Mexico Karel Fucikovsky, Pharma Director at Pierre Fabre Mexico Juan Luis Serrano, Life Sciences and Intellectual Property Partner at Sánchez Devanny

11:15

HOW TO THRIVE IN THE NEW CENTRALIZED PURCHASING SCHEMESSY

Moderator: Benjamin Vega, Commercial DIrector of Allen Laboratories Panelists: Marco Ruggiero, General Manager of Chiesi Mexico José Luis Ortiz, Director General of Medistik Carlos Gutierrez Muñoz, Account and Sourcing Implementation Director of Christus CEI 12:00

NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS

12:45 IMPORTANCE OF PREVENTION AND COST OF CHRONIC DISEASES Speaker: David Kershenobich, Director General of INCMNSZ 13:30

VALUE-BASED HEALTHCARE: A NOVEL APPROACH TO CARE

Moderator: Rosa María Galindo Suárez, Corporate Affairs and Access Director of GSK Panelists: Diego Guarin, Regional Market Access Lead for Latin America of Merck MSD Augusto Muench, CEO of Boehringer Ingelheim Mexico, Central America and Caribbean Javier Pico, Partner of LifeSciences Consultants Sandra Sánchez-Oldenhage, President of PharmAdvice Consulting 14:15

NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS


9

J a n u ar y 2 7 T H , 2 0 2 1

15:00

DIAGNOSING HEALTHIER SCENARIOS, STRENGTHENING HEALTHCARE PROVISION

Moderator: Montserrat Galindo, Market Access Manager of 3M Healthcare Division Panelists: Alejandro Paolini, Vice President of AMID Cesar Marron, General Manager of Cardinal Health Mexico Adriana De Villa, Commercial Director of Atramat 15:45

CANNABIS: WINDOW OF OPPORTUNITIES

Moderator: Erick Ponce, Cannabis Industry Promoting Group (GPIC) Panelists: Cristina Viruega, Director General of TIC INTL Fernando Becerril, Senior Partner of Becerril, Coca & Becerril (BC&B) Guillermo Nieto, President of The Mexican Association of the Cannabis Industry (ANICANN)

17:00

NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS

19:00

END OF DAY 1

J a n u ar y 2 8 T H , 2 0 2 1

09:00

RUNNING AGAINST THE CLOCK: DEVELOPING A COVID-19 VACCINE

Speaker: Cecilia Padierna, Business Development Manager of LEI Panelists: Yolanda Cervantes, Vaccine Medical Director at GSK Mexico Mario Sturion, Managing Director of Janssen Mexico Juan Silanes, CEO of Inosan Biopharma 10:00

OUT-OF-POCKET EXPENDITURE VS COVID-19

Moderator: Eduardo Lara, Vice President, Head of Health Latin America of Reinsurance Group of America (RGA) Panelists: Héctor Martínez-Said, President of the Mexican Society of Oncology (SMEO) Javier Potes, Director General of Consorcio Mexicano de Hospitales (CMH) Eduardo Garcia Luna, Vice Chancellor Of Health Sciences of UDEM 10:45 DEVELOPING A COVID-19 DIAGNOSIS TEST – BIOMÉRIEUX Speaker: Héctor Barillas, Director General of bioMérieux 12:00

NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS

12:45

PHARMACY-ADJACENT MEDICAL OFFICES: SOLUTION TO INCREASE ACCESS

Moderator: Lourdes López, Executive Director of the National Association of Medicine Distributors (ANADIM)


10

J a n u ar y 2 8 T H , 2 0 2 1

Panelists: Santiago Gonzalez Reyes, Operations Director of Farmacias YZA Gabriel Zavala, Executive Commercial Director of Farmacias del Ahorro Juan José Aguirre, Commercial Director of Grupo Bruluart 13:30

TELEMEDICINE TO INCREASE HEALTHCARE ACCESS: THE IMPACT OF COVID-19

Moderator: José Antonio Crespo, CEO of Farmalisto Panelists: Juan Manuel Cáceres, CEO of Aidicare Christian López-Silva, Partner and Head of Healthcare & Life Sciences at Baker McKenzie Ricardo Moguel, Country Manager for Mexico, Colombia and Argentina at Doctoralia Alessio Hagen, Director of Smart Cities Latin America of Dell Technologies 14:15

NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS

15:00

TECHNOLOGY ENHANCING PATIENT CARE

Moderator: Mario Sicilia, Member of the Board of Laboratorio Medico Polanco and Managing Partner of ProActive Capital Panelists: Jesus Diaz Garaygordobil, CIO of Christus Muguerza Ricardo Renteria, Sales Management Enterprise Lead Latam of Amazon Web Services (AWS) Mario Muniz, General Manager North LATAM of IQVIA Enrique Mendez, Territory Account Manager of Ergotron 15:45

INTERNATIONAL PERSPECTIVES OF COVID-19

Speaker: Corin Robertson, Her Majesty’s Ambassador to the British Embassy in Mexico 17:00

NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS

19:00

END OF MEXICO HEALTH SUMMIT 2021


11

S e pt e mb e r 8 T H , 2 0 2 1

09:00

DIPLOMACY, SOLIDARITY STAND AGAINST WORST GLOBAL PANDEMIC

Speaker: Martha Delgado Peralta, Undersecretary for Multilateral Affairs and Human Rights at Mexican Ministry of Foreign Affairs

09:30

MEXICO OUTLOOK IN 2022: PREPARE TO CAPTURE BUSINESS OPPORTUNITIES AMID A CHALLENGING OPERATING ENVIRONMENT

Speaker: Alejandro Valerio, Associate Practice Leader Mexico and Central America of FrontierView

10:00

PUBLIC-PRIVATE COLLABORATIONS TO CREATE HIGH-QUALITY SERVICES

Moderator: Hector Valle, Executive President of Funsalud Panelists: Javier Potes, Director General of CMH Raul Anaya Nuñez, Director General of Certificación at Consejo de Salubridad General Patrick Devlyn, President of the Health Commission at CCE 10:45

BOOSTING HEALTHCARE UTILIZATION BY ADDRESSING FINANCIAL HARDSHIP

Moderator: Javier Potes, Director General of CMH Panelists: Horacio Garza Ghio, Health System General Director of CHRISTUS MUGUERZA Gustavo Fernandez, CEO at Grupo Torre Médica Paula Garavito, Managing Director at AXA/Keralty Cesar Carrasco, Excecutive Managing Director at Hospitales San Angel Inn 11:30

NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS

12:30

GOING BEYOND THE VIDEO CALL: THE FUTURE OF STAKEHOLDER ENGAGEMENT

Speakers: Lance Hill, CEO of Within3 Estefanía Torres, Therapeutic Area Lead Immunology Director of Takeda 13:15

BETTER CARE THROUGH AN INTERCONNECTED HEALTH SYSTEM

Moderator: Georgina García, President of Cluster Médico Jalisco Panelists: Jose Solis Padilla, Senior Administrator for International Business Development of Mayo Clinic Jorge Camargo, CEO of ECARESOFT Esteban López, MD Healthcare and Life Sciences Market Lead for the Americas at Google Cloud Sandra Sánchez-Oldenhage, President of PharmAdvice 14:00

NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS

15:00 HEALTH SERVICES CONTINUITY: PANDEMIC AND POST-PANDEMIC SCENARIOS Moderator: Américo García, VP and Director General of Apotex Latam Panelists: Rafael Enrique Maciel Martínez, President of Asociación Mexicana de Genéricos (AMEGI) Enrique Culebro Karam, Director of Central Media


12

S e pt e mb e r 8 T H , 2 0 2 1

Edilberto Peña de León, Director General of CISNE Mexico Iván Encalada Díaz, Vice President of Consejo Mexicano de Ortopedia y Traumatología AC Leopoldo Cavazos Castro, Health Regulation Consultant at MYC Asociados 16:00

AN INTEGRAL APPROACH TO HEALTH PREVENTION

Moderator: Guillaume Corpart, Managing Director of Global Health Intelligence Panelists: Jaime Fragoso, Director of Processing Centers of LMP Eduardo Lara, Vice President, Head of Health Latin America at RGA Fernando J. Cruz, Country President and Head of Corporate Affairs and Communication at Novartis Group Mexico Gabriela Allard, President at Mexican Diabetes Association 17:00 HEALTHCARE ACCESS AS A NATIONAL PRIORITY Speaker: Manuel Cervantes Ocampo, Coordinator of First Level Medical Units at IMSS 17:30

NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS

19:00

END OF DAY 1

S e pt e mb e r 9 T H , 2 0 2 1

09:00

COMPROMISED MEDICINE SUPPLY: THREAT TO PUBLIC HEALTH

Moderator: Rafael Gual, Director General of CANIFARMA Panelists: Orlando Aguirre, Government Sales Director, Market Access & Pricing of Merck Group Benjamin Vega, Commercial Director of Allen Laboratories Juan Luis Serrano Leets, Partner- Life Sciences at Sánchez Devanny Jesús Arenas Wiedfeldt, Corporate Communication Director of Maypo Enrique Liñero, Country Head at Sandoz 10:00

COUNTERFEIT DRUGS: THE IMPACT ON THE PHARMACEUTICAL INDUSTRY

Speaker: Gary Pond, Global Product Authentication Lead of Colorcon 10:45 ACCELERATED PATHWAYS FOR ACCESS TO PHARMACEUTICAL INNOVATION Moderator: Cynthia Ramírez, Communications Director of AMIIF Panelists: Cristobal Thompson, Executive Director of AMIIF Florencia Davel, VP, General Manager, Latin America at Bristol Myers Squibb Antonio Loaeza, Country Medical Director at Sanofi Genzyme Angeles Martínez, Senior Principal and Head of Consulting, North LatAm at IQVIA 11:30

NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS


13

S e pt e mb e r 9 T H , 2 0 2 1

12:30

INTEGRATION OF HEALTH ECOSYSTEMS 5.0

Moderator: Alejandro Ruiz, Health Industry Global Head at Multiplica Panelists: Carlos Flores, Chief Innovation Officer of Nadro Hector Sobrino, Director of Health Services and Transformation of AXA/Keralty Jesus David Diaz Garaygordobil, CIO at CHRISTUS MUGUERZA 13:15

IMPACT OF THE DIAGNOSIS IN THE FIGHT AGAINST ANTIMICROBIAL RESISTANCE

Moderator: David Godínez, Medical Advisor of bioMérieux Panelists: Hector Barillas, Director General of bioMérieux Suria González, Infectionist of bioMérieux Julian Jiménez, Lab Specialist of bioMérieux 14:00

NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS

15:00

VALUE-BASED INVESTMENT FOR STATE-OF-THEART MEDICAL DEVICE TECHNOLOGY

Moderator: Ana Riquelme, Executive Director of AMID Panelists: Alejandro Paolini, Managing Director - Mexico, Central America & the Caribbean at Siemens Healthineers Juan Gabriel Gay, Managing Director at TI Salud Héctor Orellana, VP North Latam at Medtronic 15:45

DATA: PRIVACY, OWNERSHIP, ETHICS, AND CYBERSECURITY

Moderator: Guillermo Bilbao, Director of Energy Business Mexico of Minsait Panelists: Fernando Gamallo, Director of Information Tchnology of Sanfer José Arriaga Murcia, CIO at Tokio Marine Mexico Pablo Cubela, IT Director of BUPA Mexico Victor Medina, Acting President at HL7 Mexico Grisell García Moncada, Head of Marketing at Acciona Mexico 16:30 WOMEN IN HEALTHCARE: THEIR EXPERIENCE AS INDUSTRY LEADERS Moderator: Massiel Nunez, Director Americas at FrontierView Panelists: Florencia Davel, VP, General Manager, Latin America at Bristol Myers Squibb María Johnson, VP of Channels for Latin America at Boston Scientific Sandra Cifuentes, Latam Area Lead of Astellas Luly de Samper, International Vice President, MEDICAL DEVICES, Latin America at Johnson & Johnson Mariana Tolovi, Managing Director, Latin America at Edwards Lifesciences 17:30

NETWORKING OPPORTUNITY - AI-POWERED 1:1 MEETINGS

19:00

END OF MEXICO HEALTH SUMMIT 2021 ECHO


www.mexicobusiness.mx


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.